Key result
Older age, use of more than one vasopressor, and higher SCAI class were independent predictors of in-hospital mortality in patients with non-AMI cardiogenic shock.
Why the study?
Cardiogenic shock is a significant economic burden, but its prevalence and outcomes in the South Bronx Hispanic and Black population were unknown.
Cohort (n=87)
No
Non-AMI cardiogenic shock in the South Bronx carries a high in-hospital mortality rate of 62%, with older age, use of multiple vasopressors, and higher SCAI class serving as independent predictors of death.
Answers are grounded in this paper and cite their sources.
Highlights non-AMI CS burden in South Bronx minorities; hypothesis-generating and requires validation before guiding care.
OBJECTIVES: Cardiogenic shock is a significant economic burden on healthcare facilities and patients. The prevalence and outcome of cardiogenic shock in the South Bronx are unknown. The aim of the study was to examine the burden of non-AMI CS in Hispanic and Black population in South Bronx and characterize their in-hospital outcomes. RESULTS: 87 patients were admitted with cardiogenic shock (60% African American, 67% male, mean age =62±15 years) of which 54 patients (62%) died. Those who died were older, had > 1 pressor, out-of-hospital arrest, arrested within 24 hours of admission, and had higher SCAI class, lactate, and ALT levels than those who were discharged. The logistic regression analysis model showed that older age ((RR=3.4 [95% CI: 3.3-3.45]), > 1 pressor (RR=3.4 [95% CI: 2.6-4.2]) and higher SCAI class (2.1 [95% CI: 1.5-2.1], all P < 0.05)) were independent predictors of mortality in patients with cardiogenic shock. Additionally, most of the patients had either Medicare or Medicaid insurance in predominantly African American study population. CONCLUSIONS: Cardiogenic shock carries a significant risk of death. Factors such as advanced age, the administration of more than one vasopressor, and a higher SCAI classification have been identified as independent predictors of mortality among inpatients with cardiogenic shock. Additionally, the progression and outcomes of the condition are influenced by variables like race (e.g., African American individuals in this study) and economic challenges, including the type of insurance coverage (e.g., Medicaid or Medicare). Further research is essential to explore strategies that could enhance survival rates in cardiogenic shock patients, with a particular focus on addressing economic and racial disparities.
No takes yet. Share an insight, caveat, or question.
Nismat Javed (2024) conducted a cohort in Cardiogenic shock (non-AMI) (n=87). Older age vs. Younger age was evaluated on In-hospital mortality (RR 3.4, 95% CI 3.3-3.45, p=<0.05). Older age, use of more than one vasopressor, and higher SCAI class were independent predictors of in-hospital mortality in patients with non-AMI cardiogenic shock.
Synapse has enriched 10 related papers. Consider them for comparative context: